InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: None

Friday, 08/06/2021 5:19:12 PM

Friday, August 06, 2021 5:19:12 PM

Post# of 462637
Stuck in the past.

Read a new article in Science today, the weekly journal of the American Association for the Advancement of Science (AAAS): Treatments for Alzheimer’s disease emerge.

And, of course, the words “Anavex,” “blarcamesine,” or “sigma-1 receptor” did not appear. Focus was solely on beta-amyloids and tau tangles.

Some verbiage on immunological approaches (Biogen’s Aduhelm, etc.).

Of course, the author is an “expert,” at Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News